VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,700 | -97.3% | 10,000 | -92.8% | 0.05% | -97.2% |
| Q2 2023 | $3,424,388 | +137.4% | 139,600 | +125.2% | 1.81% | +104.9% |
| Q1 2023 | $1,442,740 | +137.5% | 62,000 | +158.3% | 0.88% | +114.8% |
| Q4 2022 | $607,440 | -27.4% | 24,000 | +20.0% | 0.41% | +21.2% |
| Q4 2021 | $837,000 | -31.3% | 20,000 | -28.6% | 0.34% | -37.0% |
| Q3 2021 | $1,219,000 | +113.5% | 28,000 | +132.0% | 0.54% | +166.3% |
| Q2 2021 | $571,000 | +54.7% | 12,071 | +67.8% | 0.20% | +26.2% |
| Q1 2021 | $369,000 | -34.3% | 7,192 | -65.8% | 0.16% | -31.0% |
| Q4 2020 | $562,000 | -37.1% | 21,000 | -19.2% | 0.23% | -49.2% |
| Q3 2020 | $893,000 | +190.9% | 26,000 | +246.7% | 0.46% | +165.7% |
| Q2 2020 | $307,000 | – | 7,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |